Douglas R. Galasko, MD
Affiliations: | Neuroscience | University of California, San Diego, La Jolla, CA |
Area:
DementiaWebsite:
http://neurograd.ucsd.edu/faculty/detail.php?id=30Google:
"Douglas Galasko"Bio:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=73
http://ucsd.photobooks.com/directory/profile.asp?setsize=10000&dbase=main&pict_id=0001460
Mean distance: 19.84 (cluster 32)
Cross-listing: Alzheimer's Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tsiknia AA, Sundermann EE, Reas ET, et al. (2022) Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity. Alzheimer's Research & Therapy. 14: 160 |
| Caldwell AB, Anantharaman BG, Ramachandran S, et al. (2022) Transcriptomic profiling of sporadic Alzheimer's disease patients. Molecular Brain. 15: 83 |
| Salmon DP, Smirnov DS, Coughlin DG, et al. (2022) Perception of Fragmented Letters by Patients With Pathologically Confirmed Dementia With Lewy Bodies or Alzheimer Disease. Neurology |
| Gollan TH, Stasenko A, Li C, et al. (2022) Autocorrection if→of function words in reading aloud: A novel marker of Alzheimer's risk. Neuropsychology |
| Tian C, Stewart T, Hong Z, et al. (2022) Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Tsiknia AA, Edland SD, Sundermann EE, et al. (2022) Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression. Molecular Psychiatry |
| Mozersky J, Roberts SJ, Rumbaugh M, et al. (2022) Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants. Journal of Alzheimer's Disease : Jad |
| Bernier RA, Banks SJ, Panizzon MS, et al. (2022) The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12284 |
| Smirnov D, Galasko D. (2022) Dynamics of neuroinflammation in Alzheimer's disease. The Lancet. Neurology. 21: 297-298 |
| Smirnov DS, Ashton NJ, Blennow K, et al. (2022) Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change. Acta Neuropathologica |